Lithium in Mood and Bipolar Disorders: Historical Development, Mechanisms, and Clinical Implications

Area of Science:

• Psychiatry and Neuroscience
• Pharmacology
• Medical History

Background:

• Lithium is a highly effective treatment for bipolar disorder, offering benefits in acute mania, mood stabilization, and suicide prevention.
• Despite its efficacy, lithium's clinical use has decreased due to perceived complexity in prescribing and monitoring compared to alternatives.
• Renewed interest in lithium stems from advances in understanding its neurobiological mechanisms and its unique antisuicidal properties.

Purpose of the Study:

• To review the historical trajectory of lithium in treating bipolar disorder.
• To examine the reasons for lithium's declining use and its current underutilization.
• To explore the neurobiological mechanisms underlying lithium's therapeutic effects and its potential role in contemporary treatment.

Main Methods:

• Narrative review of historical literature and clinical trials.
• Analysis of factors contributing to changes in lithium prescription patterns.
• Synthesis of current research on lithium's molecular and neuroimaging mechanisms.

Main Results:

• Lithium was established as the first mood stabilizer with proven efficacy in acute mania and prophylaxis, demonstrating relapse prevention and reduced suicide risk.
• Declining use is attributed to concerns about toxicity, monitoring requirements, and the availability of newer agents.
• Neuroscientific research highlights lithium's action on key pathways, including inositol metabolism, GSK-3 inhibition, and neuroprotection, linking cellular effects to clinical benefits.

Conclusions:

• Lithium is an underutilized but not obsolete treatment for bipolar disorder.
• Reappraising lithium historically and mechanistically supports its consideration as a first-line mood stabilizer, especially for suicide risk.
• Careful monitoring and informed patient-clinician decision-making are crucial for optimizing lithium therapy.